Dr Richard Lipscombe, Managing Director of Proteomics International (ASX:PIQ), spoke with 2GB’s...
Early detection for oesophageal cancer – Medical Forum
Proteomics International Laboratories’ (Proteomics International) blood test uses biomarkers – protein ‘fingerprints’ – to diagnose oesophageal adenocarcinoma and the pre-malignant condition, Barrett’s oesophagus, with the aim of detecting the disease sooner and potentially improving health outcomes.